AbCellera Provides COVID-19 Program Update with the Start of Phase 3 Clinical Trials and the Expansion of its COVID-19 Antibody Database Read more
Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China Read more
FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma Read more
Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate Read more
Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine Read more
FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma Read more
SAB Biotherapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of SAB-176 for Seasonal Influenza Read more